Prestige Consumer Healthcare Inc.
PBHHealthcareNASDAQDrug Manufacturers - Specialty & Generic
Scan Results
Daily timeframePrestige Consumer Healthcare Inc., together with its subsidiaries, develops, manufactures, markets, distributes, and sells over the counter (OTC) health and personal care products in North America,. At a $2.26B market cap, Prestige Consumer Healthcare Inc. ranks as a mid-cap company within healthcare. It operates in two segments, North American OTC Healthcare and International OTC Healthcare.
Market Cap
$2.26B
Beta
0.34
P/E (TTM)
13.39
P/E (Fwd)
9.41
EPS (TTM)
$3.57
EPS (Fwd)
$5.08
ROE
9.1%
ROA
4.6%
Cash
$89.1M
Total Debt
$2.07B
Free CF
$147.9M
52W Change
-23.4%
Annual Financials
Cash vs Debt
Where PBH stands vs its 150-day and 200-day moving averages
As of the October 9, 2026 close, PBH finished 7.57% below its 150-day moving average ($51.79) and 13.36% below its 200-day moving average ($55.25). This snapshot is end-of-day data shown with a five-trading-day delay on the free plan; Premium members see readings from the latest close.
Is PBH overbought or oversold?
At the October 9, 2026 close, PBH's RSI(14) was 62.7, in neutral territory (between 30 and 70). The MACD histogram was positive, so short-term momentum leaned bullish at that close. These readings are historical, refresh daily after market close, and are not investment advice.
On the balance sheet, PBH has $89.1M in cash with $2.07B in obligations. The ability to service this debt comfortably depends on continued operational cash generation. Annual free cash flow of $147.9M supports ongoing capital allocation decisions and provides a cushion against unexpected expenses or downturns. Return on equity stands at 9.1%, which is decent for the sector. ROE measures how effectively a company uses shareholder capital to generate profits. ROA of 4.6% is on the lower side, which is common in asset-heavy industries. Revenue has been relatively flat, moving from $1.13B (2023) to $1.09B (2026).
The relatively low beta of 0.34 suggests PBH is a less volatile holding compared to the broader index. Debt significantly exceeds cash reserves, which means the company's financial flexibility could be constrained during economic downturns. No single metric tells the full story. Reviewing PBH's risk profile alongside its fundamentals and technical indicators provides a more complete picture.